Pharmaceuticals

Sotorasib Tablets Market Expansion Outlook: $3.03 Billion by 2029 Forecast

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Sotorasib Tablets Market From 2025 To 2034?

The market size for sotorasib tablets has experienced rapid expansion in recent years. It is projected to increase from $1.71 billion in 2024 to $1.92 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.5%. The historical growth of this market can be attributed to the rising prevalence of non-small cell lung cancer, increasing awareness of targeted cancer therapies, the growing adoption of precision medicine, the expansion of oncology treatment centers, and enhanced government support for cancer drugs.

The sotorasib tablets market size is expected to experience substantial growth in the coming years, projected to reach $3.04 billion by 2029 with a compound annual growth rate (CAGR) of 12.1%. This anticipated expansion can be attributed to increased investment in KRAS inhibitor research, the scaling up of sotorasib manufacturing capacity, a rise in collaborations between biotech and pharmaceutical companies, growing demand for personalized cancer treatments, and the expanding use of oral targeted therapies. Key trends during the forecast period include technological advancements in developing targeted therapies, improvements in KRAS mutation detection methods, significant research and development investment in oncology drugs, innovations in oral cancer formulations, and progress in sustainable drug manufacturing practices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28336&type=smp

What Are The Drivers Pushing New Developments In The Sotorasib Tablets Market?

The increasing incidence of cancer is anticipated to fuel the expansion of the sotorasib tablets market moving ahead. Cancer refers to various diseases characterized by the uncontrolled proliferation of abnormal cells, which can invade tissues and disseminate throughout the body. This surge in cancer cases is linked to an aging population, given that older age represents the primary risk factor for developing most cancer types, with the bulk of diagnoses found in those above 65 years old. Sotorasib tablets function by specifically and permanently deactivating the KRAS G12C mutation, thereby locking the altered protein in an inactive state to hinder unchecked cell growth in individuals with advanced solid tumors, especially non-small cell lung cancer. For example, the World Health Organization, a Switzerland-based global health authority, reported in February 2024 that forecasts suggest more than 35 million new cancer diagnoses by 2050, marking a 77% rise from the projected 20 million cases in 2022. Consequently, the growing incidence of cancer is propelling the sotorasib tablets market forward.

What Are The Major Segments Identified In The Sotorasib Tablets Market?

The sotorasib tablets market covered in this report is segmented as

1) By Dosage Form: 40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms

2) By Patient Demographics: Adolescents, Adult, Senior Adults

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By Application: Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications

5) By End-User: Hospitals, Oncology Centers, Clinics, Other End-Users

Which Key Trends Are Expected To Influence The Sotorasib Tablets Market In The Coming Years?

Leading companies within the sotorasib tablets market are prioritizing the creation of novel therapies, specifically combination treatments, with the aim of enhancing effectiveness and counteracting resistance. Such combination therapies involve the concurrent administration of two or more drugs to address cancer via various mechanisms, thereby boosting treatment efficacy, mitigating or postponing drug resistance, lowering the chances of cancer recurrence, and elevating overall patient prognoses and well-being. A notable example is Amgen Inc., a US-based biotechnology firm, which secured U.S. Food and Drug Administration (FDA) clearance in January 2025 for sotorasib, when used alongside panitumumab, for treating adult patients with KRAS G12C–mutated metastatic colorectal cancer (mCRC) who had undergone prior standard chemotherapy. This authorization stemmed from findings of the Phase 3 CodeBreaK 300 study, revealing that this combined approach significantly more than doubled progression-free survival in contrast to standard-of-care therapy chosen by investigators, thus presenting a crucial new alternative for individuals battling this challenging cancer. Sotorasib itself is an pioneering, oral KRAS G12C inhibitor, functioning by precisely targeting and immobilizing the mutated KRAS protein in its dormant form, consequently impeding the proliferation of cancer cells and the signaling cascades prompted by this specific mutation.

Which Global Market Leaders Are Shaping The Future Of The Sotorasib Tablets Sector?

Major companies operating in the sotorasib tablets market are Amgen Inc., Ziska Pharmaceuticals Limited, Everest Pharmaceuticals Inc., Lucius Pharmaceutical Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sotorasib-tablets-global-market-report

Which Regional Markets Are Contributing Most To The Sotorasib Tablets Industry Expansion?

North America was the largest region in the sotorasib tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sotorasib tablets report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Sotorasib Tablets Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28336&type=smp

Browse Through More Reports Similar to the Global Sotorasib Tablets Market 2025, By The Business Research Company

Tablets Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tablets-global-market-report

Ashwagandha Extract Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ashwagandha-extract-global-market-report

Cholinergic Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cholinergic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795